Rebound Hypertension Upon Antihypertensive Discontinuation

Primary Culprits

The American College of Cardiology recommends that clonidine must be tapered gradually over 2-4 days to avoid potentially life-threatening hypertensive crisis when discontinuing therapy 1, 2
Abrupt discontinuation of clonidine can induce hypertensive crisis, with symptoms including nervousness, agitation, headache, tremor, and rapid blood pressure elevation accompanied by elevated plasma catecholamines 1, 2
Oral clonidine tablets carry higher risk than transdermal patches due to the need for frequent administration and greater likelihood of nonadherence 3

The American College of Cardiology emphasizes that all beta-blockers require gradual tapering to avoid rebound hypertension, as emphasized across multiple ACC/AHA guidelines 1, 2
Specific agents requiring caution include metoprolol, propranolol, nadolol, carvedilol, nebivolol, acebutolol, penbutolol, and pindolol 1, 2

For beta-blockers alone, the American College of Cardiology recommends tapering gradually over 1-2 weeks, particularly in patients with coronary artery disease 1, 2
Avoid abrupt cessation in all patients when discontinuing beta-blockers 1, 2

The American College of Cardiology suggests using vasodilatory drugs rather than restarting the withdrawn medication if rebound hypertension occurs 4

The American College of Cardiology recommends tapering clonidine over 2-4 days minimum when discontinuing in patients on atenolol, after first withdrawing the beta-blocker several days before beginning the clonidine taper 5

Clonidine should be avoided entirely in most hypertensive patients and is reserved as last-line therapy due to significant CNS adverse effects and withdrawal risks, according to the European Heart Journal and the American College of Cardiology 6, 5
The American College of Cardiology recommends using safer alternatives such as ACE inhibitors, ARBs, calcium channel blockers, and thiazide diuretics, which do not cause rebound hypertension 5